Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke

NCT03296618 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Motor Stroke, Chronic

Interventions

DRUG: NSI-566

Sponsor

Suzhou Neuralstem Biopharmaceuticals